Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be? ; volume:31 ; number:11 ; day:20 ; month:10 ; year:2023 ; pages:424-425 ; date:11.2023
Netherlands heart journal ; 31, Heft 11 (20.10.2023), 424-425, 11.2023
- Creator
-
Selvarajah, Abi
Hermanides, Renicus S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-023-01825-9
- URN
-
urn:nbn:de:101:1-2024011511163390115803
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Selvarajah, Abi
- Hermanides, Renicus S.
- SpringerLink (Online service)
Other Objects (12)
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Antiplatelet agents
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
11001 Pa 3 Parlamentsreform.- Adhoc-Kommission: Parlamentsreform.- Adhoc-Kommission
Adhoc-Ausschuß "Sprachverschleierung"
Outcomes of Elective Percutaneous Peripheral Revascularization in Outpatients: 10-Year Single Center Experience
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Adhoc Arbeitsgruppe Land/Entwicklungsgesellschaft
Ad-hoc Arbeitsgruppe "Drehgestellgüterwagen"
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Antiplatelet agents
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
11001 Pa 3 Parlamentsreform.- Adhoc-Kommission: Parlamentsreform.- Adhoc-Kommission
Adhoc-Ausschuß "Sprachverschleierung"
Outcomes of Elective Percutaneous Peripheral Revascularization in Outpatients: 10-Year Single Center Experience
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Adhoc Arbeitsgruppe Land/Entwicklungsgesellschaft
Ad-hoc Arbeitsgruppe "Drehgestellgüterwagen"
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Antiplatelet agents
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
11001 Pa 3 Parlamentsreform.- Adhoc-Kommission: Parlamentsreform.- Adhoc-Kommission
Adhoc-Ausschuß "Sprachverschleierung"
Outcomes of Elective Percutaneous Peripheral Revascularization in Outpatients: 10-Year Single Center Experience
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Adhoc Arbeitsgruppe Land/Entwicklungsgesellschaft